BETTY NOBLE: Open Payments
NPI 1336794411 · JACKSON, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$524 in 27 payments from 8 companies in 2025. Trend: 2023 $546 · 2024 $717 · 2025 $524
Food & beverage: $524
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 5 | $108 |
| Indivior Inc. | 5 | $97 |
| ABBVIE INC. | 5 | $95 |
| Lilly USA, LLC | 4 | $72 |
| PFIZER INC. | 3 | $63 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $51 |
| Braeburn Inc. | 1 | $22 |
| Verona Pharma, Inc. | 1 | $17 |
Products named: TRELEGY ELLIPTA, SUBLOCADE, QULIPTA, NURTEC ODT, CAPLYTA, MOUNJARO, ZEPBOUND, BRIXADI.
Industry payments across KY — which companies pay providers there.
